Singular Genomics Systems Inc (OMIC)
0.3944
+0.01
(+1.41%)
USD |
NASDAQ |
Apr 19, 14:24
Singular Genomics Systems SG&A Expense (Quarterly): 13.13M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 13.13M |
September 30, 2023 | 13.25M |
June 30, 2023 | 14.89M |
March 31, 2023 | 13.20M |
December 31, 2022 | 11.75M |
September 30, 2022 | 11.96M |
June 30, 2022 | 12.18M |
March 31, 2022 | 11.38M |
Date | Value |
---|---|
December 31, 2021 | 10.22M |
September 30, 2021 | 8.551M |
June 30, 2021 | 6.201M |
March 31, 2021 | 3.654M |
December 31, 2020 | 1.769M |
September 30, 2020 | 1.698M |
June 30, 2020 | 1.443M |
March 31, 2020 | 1.377M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.377M
Minimum
Mar 2020
14.89M
Maximum
Jun 2023
8.541M
Average
10.80M
Median
SG&A Expense (Quarterly) Benchmarks
Bruker Corp | 211.80M |
Azenta Inc | 78.58M |
Harvard Bioscience Inc | 11.51M |
Bionano Genomics Inc | 15.69M |
Akoya Biosciences Inc | 18.90M |